Principal Investigator

Jose A. Lasalde-Dominicci, Ph.D.

Addresses

Departments of Biology & Chemistry
Julio García Díaz 111, 114, 115
University of Puerto Rico
PO Box 23360
San Juan, Puerto Rico 00931-3360
JGD Laboratory: 787-764- 0000 ext 88125, 88126, 88127, 88128
Molecular Science Research Center

Lab: 223-224
Phone: 787-523- 5325
http://www.upr.edu/CiCiM
e-mail: jlasalde@gmail.com/ jose.lasalde@upr.edu
http://www.nachr.org/
http://www.cifupr.org/

Education
1983-1988 Ph.D. Biochemistry
(mentors: Dr. Gladys Escalona &
Dr. José del Castillo)
Department of Chemistry
University of Puerto Rico
Río Piedras Campus
1977-1982 B.S. Biochemistry Department of Chemistry
University of Puerto Rico
Río Piedras Campus
Post-Doctoral Training
1991-7/1996 Research Associate
Ion-Channel Structure
(Dr. Mark McNamee)
Dept. of Biochemistry & Biophysics UC Davis, Davis CA
1988-1991 Research Associate
Electrophysiology
Patch-Clamp Techniques
(Mentors: Dr. José del Castillo
and Dr. Conchita Zuazaga)
Institute of Neurobiology
University of Puerto Rico
Medical Sciences Campus
6/26/ – 9/25/1990 Summer Training
Molecular Biology
(Dr. William Gilly)
Stanford University
Hopkins Marine Station of
Stanford University
Other Training
5/1996-9/1996 Summer Sabbatical
(Dr. Stuart Forman’s laboratory)
Harvard Medical School
Department of Anesthesiology
Boston, MA
2002 Summer Research
(Dr. Raymond Steven’s Laboratory)
Scripps Clinics, San Diego, California
Academic Appointments
1/3/2017-01/31/2018 Executive director MSRC University of Puerto Rico
9/16/2013-1/31-2017 Vice President for Research
and Technology (in kind)
University of Puerto Rico
5/2013-9/15/2013 Interim President- UPR
11/22/2010-5/2013 Vice President for Research
and Technology (in kind)
University of Puerto Rico
12/2011-present Adjunct Professor Institute of Neurobiology
University of Puerto Rico
Medical School
6/2006-present Adjunct Professor Department of Comparative Medicine
University of Puerto Rico
Medical Sciences Campus
6/2003-present Professor Department of Biology
University of Puerto Rico
San Juan, Puerto Rico
7/1998-present Associate Professor Department of Biology
University of Puerto Rico
San Juan, Puerto Rico
8/6/1996-6/31/1998 Assistant Professor Department of Biology
University of Puerto Rico
San Juan, Puerto Rico
8/1994-8/1997 Associate Biochemist Molecular & Cellular Biology
Division of Biological Sciences
UC Davis, Davis CA 95616
Other Professional Appointments & Major Visiting Appointments
12/2013-present Puerto Rico Science and Technology Trust Board of Directors
10/2012- 01/ 2017 Material Characterization Center Board of Directors-President
11/2011-present UPR-Molecular Science Building Board of Directors-Vice President
10/2010- present INDUNIV (PRIDCO) Board of Directors-Vice President
Summer 1997 Visiting Scientist Department of Anesthesiology
Harvard Medical School
01-05/1987 Professor of Biochemistry University of Puerto Rico
Río Piedras, P. R.
Awards & Honors
1981-1983 National Institutes of Health -MBRS undergraduate Student fellowship
1984-1998 National Institutes of Health -MBRS Graduate Student fellowship
1989-1992 National Institutes of Health -MARC Post-Doctoral Fellowship award
1992-1996 National Institutes of Health -NIGMS –Post-doctoral Research Award
5/1999 National Science Foundation Productivity Award
7/1999 Glaxo-Wellcome Research Award
6/2000 Academia de Artes y Ciencias de Puerto Rico
6/2008-present Member Editorial Board of Cellular and Molecular Neurobiology (Springer)
8/2008-present Member of the IUPAC DIVISION-III BIOMOLECULAR SUBCOMMITTEE
Major Committee Assignments
1992-1996 Laboratory Security Molecular & Cellular Biology
Division of Biological Sciences
UC Davis, Davis CA 95616
1996-1998 Library Committee Department of Biology
University of Puerto Rico
Río Piedras Campus
1998-present MBRS Advisory Committee Faculty of Natural Sciences
University of Puerto Rico
Río Piedras Campus
1998-present MARC Advisory Committee Faculty of Natural Sciences
University of Puerto Rico
Río Piedras Campus
1998-2003 RCMI Advisory Committee Universidad Central del Caribe
School of Medicine (UCC)
6/2000-present Director Confocal Imaging Facility
(www.cifupr.org)
Department of Biology
University of Puerto Rico
Río Piedras Campus
8/2000-2002 Graduate School Committee Department of Biology
University of Puerto Rico
Río Piedras Campus
8/2002-2004 Personnel Committee Department of Biology
University of Puerto Rico
Río Piedras Campus
8/2001-8/2003 National Science Foundation, Neuronal & Glial Mechanisms Panel member
5/2004-5/2005 MD Anderson-UPR Steering Committee
7/2003-5/2004 Chair UPR Biomolecular Building Committee
6/2003-6/2005 National Institute of Health, National Research Service Award (NRSA) panel member, Structural Biology.
6/2005-5/2007 Reviewer for the Philip Morris External Research Program
6/2000-11/2005 Mentor for the “Successful grant writing” NIGMS initiative at the University of Kentucky.
04/2005-3/2011: Appointed as Scientific Director for the SNRP program at UPR-RCM campus
(http://snrp.rcm.upr.edu/investig.html).
01/07/2013-present: Director of the COBRE Neuroimaging and Electrophysiological Facility (NIEF)
6/2016-present: National Institute of Health, National Research Service panel member; at NIH/NIGMS, pa NeuroAids SEP ZRG1 AARR M 02: “AIDS and AIDS related research” for 2018/07/26/2018, council round, “HIV/AIDS Special Emphasis Panels (ZRG1 F17-M 20) 03/01/2018 and NIH/NIGMS Centers of Biomedical Research Excellence (COBRE) Phase III Translational Center panel, 11/02/2017.
Major Research Interest (see http://nachrs.org/projects.html):

Acetylcholine receptor structure and function, lipid-protein interactions in biological membranes, neuronal acetylcholine receptor and nicotine addiction, electrophysiological analysis of slow-channel congenital myasthenic syndromes (SCCMS) associated with point mutations in the genes encoding acetylcholine receptor subunits. Molecular basis for neuronal nicotinic receptor upregulation: potential implications in HIV associated dementia.

Research Funding Information
Past

1988-1991: National Institute of Health MARC Postdoctoral fellowship, “Membrane cholesterol affects acetylcholine receptor-channel function. ($90,000)

1992-1996: National Institute of Health NIGMS Postdoctoral fellowship, “Mutagenesis of nicotinic acetylcholine receptor-channel function. ($200,000).

7/97-7/99 National Science Foundation-EPSCOR- 7/97 to 7/99, P.I., “Molecular basis of Neuronal Acetylcholine receptor desensitization” ($146,000) (Principal Investigator).

1/99-12/2001, National Institute of Health ²Postdoctoral Research Supplement” 5/1/997- 4/30/2002

($223,000) (Principal Investigator José A. Lasalde Dominicci, Co-PI Mark McNamee UC Davis).

6/2000-8/2004,“General anesthetic interaction with lipid-exposed domains of the acetylcholine receptor”. period: 6/2000-8/2004 National Institute of Health-NIGMS-SCORE. Principal Investigator: José A. Lasalde Dominicci, Type: Institutional Minority Training Grant SCORE program NIGMS NIH MBRS S06 GM08102, cost $595,482. The goal of this project is to define the allosteric sites of the M4 trasmembrane segment of the Torpedo AChR. This project focus on the interaction of general anesthetics with lipid exposed mutations on the M4 domain an also the analysis of 3 lipid exposed allosteric positions.  Principal Investigator: José A. Lasalde Dominicci, Ph.D. Type: Institutional Minority Training Grant SCORE program NIGMS (NIH MBRS S06 GM08102) .

01/01/1999-7/31/2004, “Acetylcholine receptor genes in slow-channel syndrome” ($1,400,000) Consortium Agreement Period: January 1, 1999 to July 31, 2004, Type: National Institute of Health-(2RO1-N33202) C0-P.I (Principal Investigator- Christopher Gómez, J.A. Lasalde-Dominicci Co-Principal Investigator). The goal of this project is to understand the pathophysiology and molecular mechanisms involved in the impairment of neuromuscular transmission in the slow channel congenital myasthenic syndrome (SCCMS).   Consortium agreement with University of Minnesota.

6/2000-7/2002. “Development of pathogenic Neuronal Nicotinic Acetylcholine receptor models” Postdoctoral Research training Supplement NIH, American Psychiatry Association ($80,000) (Principal Investigator Maria Reyes, M.D., Co-Investigator: José A. Lasalde Dominicci.  The long-term goal of this project is to develop transgenic mice models for pathogenic cholinergic pathways in the CNS. The proposed research will focus on the construction and electrophysiological characterization of two pathogenic mutations recently found in the muscle type AChR (b1V229F and a1V249F) at homologous positions in the α4 neuronal subunit. These two mutations have been found in two myasthenic patients with the slow-channel (SCCMS).

7/2000-8/2003, “Molecular Basis of neuronal nicotinic receptor up-regulation and nicotine addiction($30,000). The goal of this research proposal is to combine electrophysiological, biochemical, molecular biological techniques and confocal imaging in order to define the structural and functional basis for the relationship between up-regulation and desensitization of the α4β2 nAChR induced by nicotine.  The mechanism by which the a4b2 nAChR number is increased in the cell surface following nicotine exposure is thought to involve reduced turnover of receptors, it has been suggested that a conformational change of the receptor prevent it from being removed from the cell surface.  The long-range goal of the proposed experiments is to gain insight into a mechanism of upregulation of the a4b2 nAChR up-regulation that has been associated to nicotine tolerance and dependence. Principal Investigator: José A. Lasalde Dominicci, Ph.D. Type: Institutional Funds (FIPI) (Years 2000-2003) Period: July 1, 2000 to December 31, 2003.

10/1998-12/2000, “Instrumentation for Confocal microscope” Principal Investigator: José A. Lasalde Dominicci, Ph.D. Type: Competitive Instrumentation NIH-NCRR (1S10RR 13705-01). This project provided Confocal Laser Scanning microscope. This system includes Krypton/Argon mixed gas laser with lines 488, 568 and 647nm; scanning imaging head; fiberoptics laser delivery; three detector channels; multichannel data acquisition; Pentium based scan control and image acquisition system. Funds awarded $236, 433.

10/1999-8/2000, “Confocal Imaging Facility Upgrade” Principal Investigator: José A. Lasalde Dominicci, Ph.D. Type: Instrumentation, National Science Foundation EPSCoR. This proposal up-grades the confocal imaging facility with an additional inverted microscope (coupled to the Zeiss 510 NLO confocal microscope) and computers programs and printers to support image analysis. Funds awarded $226,000.

10/1998-10/1999, “Automated DNA sequencing instrumentation Facility” NSF-EPSCoR Shared Instrumentation grant, Awarded (3/15/1999)  Principal Investigator: Owen McMillan, Ph.D. Co- Investigator: José A. Lasalde Dominicci, Ph.D. Funds awarded $165,000.

5/1999-8/2000, “A twophoton laser application for confocal imaging” NSF EPSCoR co-funding Principal Investigator: Fernando Santana, Ph.D., Co-Principal Investigator: José A. Lasalde Dominicci, Ph.D. Funds awarded $232,000

09/1997-04/31/2009 Type: 2R01GM56371-12, Funds awarded $2,497,000.  “Cholesterol and lipid protein interactions affect acetylcholine channel function” (Investigates the effects of cholesterol and lipid exposed mutation on the Torpedo and muscle-type AChR channel function). Principal Investigator: José A. Lasalde Dominicci, Agency National Institute of General Medical Sciences (NIGMS). The conformational transitions of the Nicotinic Acetylcholine receptor (AChR). We decoded a network of hydrophobic allosteric sites located at lipid exposed of the M3 transmembrane segment. The main hypothesis is that an exclusive group of lipid-exposed positions might play a critical role in the channel function through physical interactions with membrane lipids that remain to be defined. This research explore specific, novel aspects of the interaction of these allosteric sites with the membrane bilayer using two approaches: lipid replacements in the intact oocyte, site specific mutagenesis of the M3 transmembrane domain of the Torpedo and muscle-type AChR and the use of nonsense suppressor methods to deliver unnatural amino acids to novel allosteric positions in transmembrane segments.

6/2004-8/2008, “Mutagenesis of nicotinic acetylcholine receptors”. period: 6/2004-8/2008 ($740,000) National Institute of Health-NIGMS-SCORE. Principal Investigator: José A. Lasalde Dominicci, Type: Institutional Minority Training Grant SCORE program NIGMS NIH MBRS S06 GM08102, cost $595,482. The goal of this project is to define the allosteric sites of the M4 trasmembrane segment of the Torpedo AChR. This project focus on the interaction of general anesthetics with lipid exposed mutations on the M4 domain an also the analysis of 3 lipid exposed allosteric positions.  Principal Investigator: José A. Lasalde Dominicci, Ph.D. Type: Institutional Minority Training Grant SCORE program NIGMS (NIH MBRS S06 GM08102).

9/2009-11/2012 Principal Investigator: José A. Lasalde Dominicci, Ph.D.  (NSF), Type: MRI Instrumentation Grant, “Emission-Fingerprinting upgrade-Confocal and Two photon Facility–Multi Campus Initiative-UPR” Submitted January 28, 2009.  The main goal of this proposal is to upgrade the applications of an existing Confocal and Two-Photon Microscopy Facility of the University of Puerto Rico (UPR), Río Piedras Campus (www.cifupr.org), to perform fluorescence emission fingerprinting – Budget allocation: $322,000.

1/2010-7/2015 Type 2RO1-N33202 “Acetylcholine receptor genes in slow-channel syndrome” ($1,400,000.013) Consortium Agreement: National Institute of Health (Principal Investigator- Christopher Gómez, J.A. Lasalde-Dominicci Co-Principal Investigator). The goal of this project is to understand the pathophysiology and molecular mechanisms involved in the impairment of neuromuscular transmission in the slow channel congenital myasthenic syndrome (SCCMS). Consortium agreement with University of Chicago.

10/2006-8/31/2013 – No Cost Extension – SNRP: “Specialized Neurosciences Research Program in NeuroAIDS”, ($1,500,000 per year) Principal Investigator: Edmundo Kraiselburd, Scientific Director, José A. Lasalde Dominicci (time effort 25%, Scientific Director). National Institute of Neurological Disorder and Stroke (U54NS0430311), National Institutes of Health. The present NeuroAIDS Program of the UPR-MSC SNRP funded by NINDS provides the ideal instrument to upgrade the level of research in HIV and neuroscience’s building on these existing clinical and basic research infrastructures and the collaboration with NIH funded scientists with skills and expertise otherwise not available in Puerto Rico. (for further information see http://snrp.rcm.upr.edu/investig.html.

10/2006-8/31/2013- No Cost Extension, – SNRP, NIH- U54NS0430311-NCE; Title: “Molecular basis for neuronal nicotinic receptor upregulation: potential implications in HAD NCE P.I. José A. Lasalde-Dominicci, Direct Cost $350,000 per year (5 years) 11/2006-10/2013.  In the project, we will use voltage-clamp whole-cell current electrophysiological recording to assess nAChR function, radioligand binding assays to ascertain numbers of a4b2-nAChR in total cell membranes and on the cell surface, site-directed mutagenesis approaches, and confocal microscopy to study the upregulation of the a4b2 and a7 nAChRs.  The aims are to: (1) define the structural and functional basis for the up-regulation of the a4b2 nAChR induced by chronic nicotine exposure, (2) develop methods to incorporate fluorescent amino acids into the nAChR subunits using nonsense suppressor techniques that will allow the study nAChRs trafficking in vivo, (3) gain insight into the molecular basis for the upregulation of the a7 nAChR induce by a combined treatment with HIV-1 gp120, nicotine and galantamine in vitro, (4) examine the functional state of the a7 nAChR after chronic exposure to gp120 in macrophages from HIV infected patients and (5) express and purify the a7 nAChR extracellular domain for crystallization trials.

Grant Number P20 RR-016470 from the National Center for Research Resources (NCRR), Period: 05/01-2009-04/31-2014. P.I. Vibha Bansal, Ph.D Screening of different sources of plasminogen activators, their inhibitors and development of new techniques for isolation of plasminogen activators, José A. Lasalde Dominicci, Ph.D. (in kind as Collaborator/Mentor).

Grant Number P20 RR-016470 from the National Center for Research Resources (NCRR), Period: 05/01-2009-04/31-2014. Margarita Ortiz, Ph.D., PI Project, José A. Lasalde Dominicci, Ph.D. (in kind Collaborator/Mentor) – “Novel synthesis of nicotinic agonists for Alzheimer’s therapy”\

NIH Clinical Grant Award $50K, PI Dr. Carlos Báez. Mentor, Dr. José Lasalde Dominicci “Bupropion as adjunctive therapy to improve immune profile in HIV seropositive smokers”, Awarded 02/11/2011 (in kind Mentor)

Clinical Bioreagent Center in PR.  HIV Vaccine pilot project CRD OISE-14-60-828-01, 06/15/2015-01/15/2016 (José A. Lasalde Dominicci, Ph.D. PI 5% in kind)

 

Present Funding

NIH-NIAID- “Optimization of HIV glycoproteins as vaccines candidates”– Principal Investigator (R01AI122935) José A. Lasalde Dominicci, Ph.D.  (in kind). More than thirty years after its discovery, the human immunodeficiency virus (HIV) continues to be a major global concern. Despite a reduction in the number of new infections worldwide (2.1 million new infections in 2013 vs. 5 million in 2005), the HIV pandemic is far from over. In the United States alone, there are nearly 45,000 new HIV diagnoses each year, with some ethnic groups being disproportionately affected. Thus, the search for a prophylactic vaccine against HIV is of paramount importance. In this project, a consortium that combines a research university, a startup biotech company and the advisory input from the local biopharmaceutical manufacturing sector, aim to optimize the pipeline for the production of HIV vaccines for clinical trials by addressing some of the hurdles that have hindered progress in this field over the years. Period: 07/01/2016 – 06/30/20

NIH-NIGMS- A lipid-based approach towards the nAChR high resolution structure.  Principal Investigator: José A. Lasalde Dominicci, Ph.D.  (NIH) R01GM098343, Period: 2/01/2013-05/31/2019.  We propose to develop a comprehensive lipid-based approach to assess the function and stability of detergent-solubilized nAChR.  The main goal of this application is to define the manner in which detergents affects the lipid composition, ion channel function, agonist binding, state of aggregation of the solubilized-nAChR and ultimately the ability to form membrane protein crystals. The objective of this application is to develop a comprehensive lipid-based approach for the selection of detergents for membrane protein crystallization.

NIH/NINDS- “The COBRE Center for Neuroplasticity at the University of Puerto Rico”.  Principal Investigator: José A. Lasalde Dominicci, Ph.D., Mark Miller Co-Investigator, Director of Confocal imaging facility, José A. Lasalde Dominicci, Ph.D.  (NCRR), Type: U54 COBRE- Budget allocation: $11,613,710.   The goal of the COBRE Center proposed in this application is to significantly enhance the quality and biomedical relevance of research by scientists at the Institute of Neurobiology, the University of Puerto Rico Medical Sciences Campus (UPR-MSC) and the UPR Río Piedras Campus (UPR-RP). Period: 01/2018-12/31/2023. Awarded on November 2012.

Collaborative Research Projects
1997-present Christopher Gómez, M.D., Ph.D., University of Chicago, Department of Neurology:

Electrophysiological characterization of acetylcholine receptor genes in slow-channel congenital myasthenic syndrome

2001-present Raymond Sevens Ph.D., Scripps Institute, San Diego, CA: “Crystallization of nicotinic acetylcholine receptor
2003-present Enrique Ochoa, M.D., Ph.D., Department of Neurology, UC Davis Medical School, University of California at Davis. “Molecular basis of neuronal nicotinic acetylcholine receptor desensitization“.

 

US Patents:

  1. Title: “High Throughput screening device for membrane proteins using a sub physiological resting membrane potential across a lipid matrix of variable composition”, was assigned and became public on December 2018. US patent 10,155,221
  2. Another patent (related to the US patent 10.155,221),  US patent 15997728 assigned on April 04, 2019.

Patent Applications (pending)

  1. Title: A Method for Predicting Increased Risk of Suffering Statin-induced Adverse Drug Reactions.
    Application number: 13/540,598
  1. Title: α4β2 nicotinic acetylcholine receptors with reduced or increased nicotine sensitivity.
    Application number: 62/153,660

This CV is condensed. For full CV click here.